The Bristol-Myers Squibb Pharmaceuticals (BMS) Pfizer Alliance is delighted to announce the first UK Value Academy Masterclass event, which will take place on Saturday 18 March.
Value Academy Masterclass is a one-day interactive meeting designed to support healthcare professionals involved in resource allocation decision-making. You are invited to join the expert faculty and colleagues from a variety of disciplines to explore the value decisions and assessments that are central to treatment choice, with a focus on novel oral anticoagulants (NOACs).
By attending this meeting, participants will:
Speakers and steering committee members include Professor Ruth Chambers OBE GP, Clinical Chair at NHS Stoke-on-Trent CCG and Lead for the Long Term Conditions Clinical Priority at West Midlands Academic Health Science Network, while Tony Jamieson, Pharmacist and Clinical Lead for Medicines at Yorkshire & Humber Academic Health Science Network, also serves on the committee.
To book your place, email Alan Strickland at BMS on alan.strickland@bms.
This promotional meeting has been funded and organised by the BMS Pfizer Alliance with the guidance of the Value Academy faculty.